Industry: Pharmaceuticals, Biotechnology
GMI is capitalizing on advances in the field of glycobiology by developing small molecule drugs that mimic the action of carbohydrates. The Company’s initial focus is on developing anti-inflammatory drugs based on selectin inhibition. ( www.glycomimetics.com )
GlycoMimetics , Inc.
101 Orchard Ridge Drive Suite 1E
Gaithersburg, Maryland 20878
USA
Tel: (240) 243-1201
Fax: (240) 243-1014